The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy

•Download as PPT, PDF•

1 like•71 views

PVI, PeerView Institute for Medical Education

The document discusses the results of a study on the impact of COVID-19 lockdowns on air pollution. The study found that lockdowns led to short-term reductions in nitrogen dioxide and fine particulate matter concentrations globally. However, the decreases in air pollution were temporary and not sufficient to significantly improve air quality or public health in the long run without systemic changes to reduce fossil fuel use and other polluting activities.

Health & Medicine

The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy

Co-Chairs, Stephen Salloway, MD, MS, and Sharon J. Sha, MD, MS, prepared useful Practice Aids pertaining to Alzheimer's disease for this CME/MOC/NCPD/AAPA activity titled “Preparing Your Practice for the New Era of Amyloid-Targeting Therapies in Alzheimer's Disease: Expert Insights on Key Evidence, Administrative and Clinical Considerations, and Best Practices for Individualized, Patient-Centered Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at https://bit.ly/3twjpAt. CME/MOC/NCPD/AAPA credit will be available until June 19, 2025.

Preparing Your Practice for the New Era of Amyloid-Targeting Therapies in Alz...

PVI, PeerView Institute for Medical Education

Co-Chairs, Stephen Salloway, MD, MS, and Sharon J. Sha, MD, MS, discuss Alzheimer's disease in this CME/MOC/NCPD/AAPA activity titled “Preparing Your Practice for the New Era of Amyloid-Targeting Therapies in Alzheimer's Disease: Expert Insights on Key Evidence, Administrative and Clinical Considerations, and Best Practices for Individualized, Patient-Centered Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at https://bit.ly/3twjpAt. CME/MOC/NCPD/AAPA credit will be available until June 19, 2025.

Candid Conversations on Modern Urothelial Cancer Management: Personalizing Pa...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Andrea Necchi, MD, Matthew D. Galsky, MD, Shilpa Gupta, MD, and Michiel S. van der Heijden, MD, PhD, prepared useful Practice Aids pertaining to bladder cancer for this CME/MOC/NCPD/AAPA/IPCE activity titled “Candid Conversations on Modern Urothelial Cancer Management: Personalizing Patient Care Using the Latest Evidence and Innovative Therapeutic Strategies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4cDsBog. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.

Candid Conversations on Modern Urothelial Cancer Management: Personalizing Pa...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Andrea Necchi, MD, Matthew D. Galsky, MD, Shilpa Gupta, MD, and Michiel S. van der Heijden, MD, PhD, discuss bladder cancer in this CME/MOC/NCPD/AAPA/IPCE activity titled “Candid Conversations on Modern Urothelial Cancer Management: Personalizing Patient Care Using the Latest Evidence and Innovative Therapeutic Strategies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4cDsBog. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.

A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection an...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Sumanta Kumar Pal, MD, FASCO, Nizar M. Tannir, MD, FACP, and Tian Zhang, MD, MHS, prepared useful Practice Aids pertaining to renal cell carcinoma for this CME/MOC/NCPD/AAPA/IPCE activity titled “A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection and Sequencing.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3xgpDpY. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 2, 2025.

A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection an...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Sumanta Kumar Pal, MD, FASCO, Nizar M. Tannir, MD, FACP, and Tian Zhang, MD, MHS, discuss renal cell carcinoma in this CME/MOC/NCPD/AAPA/IPCE activity titled “A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection and Sequencing.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3xgpDpY. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 2, 2025.

Taking a Closer Look at Each Patient: Exploring Novel Biomarker and Imaging S...

PVI, PeerView Institute for Medical Education

Co-Chairs, Amit Bar-Or, MD, FRCPC, and Jiwon Oh, MD, PhD, FRCPC, prepared useful Practice Aids pertaining to multiple sclerosis for this CME/NCPD/CPE/IPCE activity titled “Taking a Closer Look at Each Patient: Exploring Novel Biomarker and Imaging Strategies in MS.” For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/IPCE information, and to apply for credit, please visit us at https://bit.ly/3IyZJQh. CME/NCPD/CPE/IPCE credit will be available until June 29, 2025.

Taking a Closer Look at Each Patient: Exploring Novel Biomarker and Imaging S...

PVI, PeerView Institute for Medical Education

Co-Chairs, Amit Bar-Or, MD, FRCPC, and Jiwon Oh, MD, PhD, FRCPC, discuss multiple sclerosis in this CME/NCPD/CPE/IPCE activity titled “Taking a Closer Look at Each Patient: Exploring Novel Biomarker and Imaging Strategies in MS.” For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/IPCE information, and to apply for credit, please visit us at https://bit.ly/3IyZJQh. CME/NCPD/CPE/IPCE credit will be available until June 29, 2025.

Chair and Presenter, Manish A. Shah, MD, FASCO, Ronan J. Kelly, MD, MBA, FASCO, and Prof. Dr. Markus Moehler, discuss gastric cancer in this CME/MOC/NCPD/AAPA activity titled “Catalysts for Change in Gastric & GEJ Cancer: Digesting New Evidence & Future Directions of Care With Innovative Immunotherapy & Targeted Platforms.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at https://bit.ly/3VHpl55. CME/MOC/NCPD/AAPA credit will be available until July 2, 2025.

Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer: Exper...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Karim Fizazi, MD, PhD, Pedro C. Barata, MD, MSc, FACP, Kim N. Chi, MD, FRCPC, and Alicia K. Morgans, MD, MPH, discuss prostate cancer in this CME/MOC/NCPD/AAPA/IPCE activity titled “Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer: Experts Put the Pressure on Key Evidence and Real-World Strategies to Optimize Patient Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3VqHUKU. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 1, 2025.

Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targ...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Yelena Y. Janjigian*, MD, Shubham Pant, MD, and John Strickler, MD, discuss HER2+ GI malignancies in this CME/MOC/NCPD/AAPA/IPCE activity titled “Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/49K4Qcb. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.

Anticoagulation Therapy in NVAF: A Quality Improvement Initiative

PVI, PeerView Institute for Medical Education

Chair Kun "Kevin" Xiang, MD, PhD, discusses atrial fibrillation in this CME/MOC/NCPD/CPE activity titled “Anticoagulation Therapy in NVAF: A Quality Improvement Initiative.” For the full presentation, downloadable Practice Aids, monograph, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at https://bit.ly/2UoPplb. CME/MOC/NCPD/CPE credit will be available until June 12, 2025.

Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communica...

PVI, PeerView Institute for Medical Education

Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...

PVI, PeerView Institute for Medical Education

Chair, William Anderson, MD, discusses severe asthma in this CME/MOC/NCPD/CPE/AAPA activity titled “Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Severe Asthma Using a Collaborative Approach: Recognition, Referral, and Management in the Era of Targeted Treatment Options.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at https://bit.ly/3IJWFAR. CME/MOC/NCPD/CPE/AAPA credit will be available until June 13, 2025.

Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...

PVI, PeerView Institute for Medical Education

Chair and Presenters Professor Stephen Johnston, MA, PhD, Patrick Neven, MD, PhD, and Joyce O’Shaughnessy, MD, prepared useful Practice Aids pertaining to breast cancer for this CME/MOC/CPD/NCPD/CPE/AAPA activity titled “Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Practical Roadmap for CDK4/6 Inhibition in the Adjuvant Setting.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CPD/NCPD/CPE/AAPA information, and to apply for credit, please visit us at https://bit.ly/49HZ5fH. CME/MOC/CPD/NCPD/CPE/AAPA credit will be available until June 21, 2025.

Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...

PVI, PeerView Institute for Medical Education

Chair and Presenters Professor Stephen Johnston, MA, PhD, Patrick Neven, MD, PhD, and Joyce O’Shaughnessy, MD, discuss breast cancer in this CME/MOC/CPD/NCPD/CPE/AAPA activity titled “Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Practical Roadmap for CDK4/6 Inhibition in the Adjuvant Setting.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CPD/NCPD/CPE/AAPA information, and to apply for credit, please visit us at https://bit.ly/49HZ5fH. CME/MOC/CPD/NCPD/CPE/AAPA credit will be available until June 21, 2025.

Cases in the Community: Optimizing Treatment and Considering Weight Managemen...

PVI, PeerView Institute for Medical Education

Chair, Javier Morales, MD, FACP, FACE, discusses Type 2 diabetes in this CME/CE/AAPA activity titled “Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People with T2DM.” For the full presentation, downloadable Practice Aids, and complete CME/CE/AAPA information, and to apply for credit, please visit us at . CME/CE/AAPA credit will be available until June 11, 2025.

Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...

PVI, PeerView Institute for Medical Education

Chair, Nicole Lamanna, MD, discusses chronic lymphocytic leukemia in this CME activity titled “Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standards, and Innovative BTKi Combinations.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at https://bit.ly/49Mazi3. CME credit will be available until June 11, 2025.

Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...

PVI, PeerView Institute for Medical Education

Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, discuss Alzheimer’s disease in this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.

Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...

PVI, PeerView Institute for Medical Education

Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.

Adapting HIV Treatment for People With Substance Use Disorder

PVI, PeerView Institute for Medical Education

Chair, Monica Gandhi, MD, MPH, prepared useful Practice Aids pertaining to HIV for this CME/MOC/CE/AAPA activity titled “Adapting HIV Treatment for People With Substance Use Disorder.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CE/AAPA information, and to apply for credit, please visit us at https://bit.ly/49hgPxT. CME/MOC/CE/AAPA credit will be available until June 4, 2025.

Adapting HIV Treatment for People With Substance Use Disorder

PVI, PeerView Institute for Medical Education

Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...

PVI, PeerView Institute for Medical Education

Chair, Carla M. Nester, MD, MSA, FASN, discusses glomerular kidney disease in this CME activity titled “Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evolving Landscape of Glomerular Kidney Disease Management.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at https://bit.ly/3wJPTs1. CME credit will be available until June 4, 2025.

Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?

PVI, PeerView Institute for Medical Education

Chair and Presenter Rohit Loomba, MD, MHSc, and Alina M. Allen, MD, MS, discuss metabolic dysfunction–associated steatohepatitis in this CME activity titled “Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at https://bit.ly/3O53xMy. CME credit will be available until June 19, 2025.

Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...

PVI, PeerView Institute for Medical Education

Co-Chairs, Prof. Mohamad Mohty, MD, PhD, and Caitlin Costello, MD, discuss refractory multiple myeloma in this CME/CPD activity titled “Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM.” For the full presentation, downloadable Practice Aids, and complete CME/CPD information, and to apply for credit, please visit us at https://bit.ly/3UFL0dt. CME/CPD credit will be available until 5 June 2025.

Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...

PVI, PeerView Institute for Medical Education

Co-Chairs, Doreen J. Addrizzo-Harris, MD, and Cedric "Jamie" Rutland, MD, discuss non-cystic fibrosis bronchiectasis in this CME/MOC/AAPA activity titled “Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understanding Disease Burden, Diagnosing Early, and Looking Toward New Management Options.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at https://bit.ly/3KlxjL9. CME/MOC/AAPA credit will be available until June 19, 2025.

Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...

PVI, PeerView Institute for Medical Education

Co-Chairs Riad Salem, MD, MBA, and Mark Yarchoan, MD, discuss liver cancer in this CME/MOC activity titled “Establishing the Collaborative Benchmark for HCC Care: Critical Discussions Between Interventional Radiologists and Oncologists to Maximize Therapeutic Benefit.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3IOQvQ6. CME/MOC credit will be available until June 14, 2025.

Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...

PVI, PeerView Institute for Medical Education

Co-Chairs, Brett Elicker, MD, and David E. Griffith, MD, ATSF, ACCP, OFRSM, prepared useful Practice Aids pertaining to non-cystic fibrosis bronchiectasis for this CME/MOC activity titled “Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: Ensuring Prompt Diagnosis Through Accurate Interpretation of CT Imaging.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/48WUULu. CME/MOC credit will be available until June 4, 2025.

Foundation of Yoga, YCB Level-3, Unit-1

Jyoti Bhaghasra

Giloy in Ayurveda - Classical Categorization and Synonyms

Planet Ayurveda

Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.

Recently uploaded

Foundation of Yoga, YCB Level-3, Unit-1

Jyoti Bhaghasra

Giloy in Ayurveda - Classical Categorization and Synonyms

Planet Ayurveda

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ - Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0 - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals

MuskanShingari

Nano-gold for Cancer Therapy chemistry investigatory project

SIVAVINAYAKPK

chemistry investigatory project The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications. Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.

PGx Analysis in VarSeq: A User’s Perspective

Golden Helix

Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings. The purpose of this webcast is to: Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis. Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting. Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.

“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...

Université de Montréal

Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8 - Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

Breast cancer: Post menopausal endocrine therapy

Dr. Sumit KUMAR

Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options. Diagnosis and Staging The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells. Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions. Treatment Options Endocrine Therapy Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include: Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events. Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen. Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops. Combination Therapies Combining endocrine therapy with other treatments enhances efficacy. Examples include: Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer. Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors. Chemotherapy Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.

pharmacy exam preparation for undergradute students.pptx

AdugnaWari

Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)

MuskanShingari

Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient. One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells. Safe methods have been devised to do this, using several viral and non-viral vectors. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. The biggest hurdle faced by medical research in gene therapy is the availability of effective gene-carrying vectors that meet all of the following criteria: Protection of transgene or genetic cargo from degradative action of systemic and endonucleases, Delivery of genetic material to the target site, i.e., either cell cytoplasm or nucleus, Low potential of triggering unwanted immune responses or genotoxicity, Economical and feasible availability for patients . Viruses are naturally evolved vehicles that efficiently transfer their genes into host cells. Choice of viral vector is dependent on gene transfer efficiency, capacity to carry foreign genes, toxicity, stability, immune responses towards viral antigens and potential viral recombination. There are a wide variety of vectors used to deliver DNA or oligo nucleotides into mammalian cells, either in vitro or in vivo. The most common vector system based on retroviruses, adenoviruses, herpes simplex viruses, adeno associated viruses.

TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...

Donc Test

TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf

Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...

FFragrant

Public Health Lecture 4 Social Sciences and Public Health

phuakl

Tele Optometry (kunj'sppt) / Basics of tele optometry.

Kunj Vihari

13. PROM premature rupture of membranes

TigistuMelak

RESPIRATORY DISEASES by bhavya kelavadiya

Bhavyakelawadiya

Call Girl Pune 7339748667 Vip Call Girls Pune

Mobile Problem

biomechanics of running. Dr.dhwani.pptx

Dr. Dhwani kawedia

The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.

Call Girls Lucknow 9024918724 Vip Call Girls Lucknow

nandinirastogi03

Recently uploaded (20)

Foundation of Yoga, YCB Level-3, Unit-1

Giloy in Ayurveda - Classical Categorization and Synonyms

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals

Nano-gold for Cancer Therapy chemistry investigatory project

PGx Analysis in VarSeq: A User’s Perspective

“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...

Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad

Breast cancer: Post menopausal endocrine therapy

pharmacy exam preparation for undergradute students.pptx

Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)

TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...

Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...

Public Health Lecture 4 Social Sciences and Public Health

Tele Optometry (kunj'sppt) / Basics of tele optometry.

13. PROM premature rupture of membranes

RESPIRATORY DISEASES by bhavya kelavadiya

Call Girl Pune 7339748667 Vip Call Girls Pune

biomechanics of running. Dr.dhwani.pptx

Call Girls Lucknow 9024918724 Vip Call Girls Lucknow

The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy

Recommended

Recommended

More Related Content

More from PVI, PeerView Institute for Medical Education

More from PVI, PeerView Institute for Medical Education (20)

Recently uploaded

Recently uploaded (20)